State of Wyoming’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.8K Buy
21,540
+4,160
+24% +$12.2K 0.01% 1583
2026
Q1
$42.9K Buy
+17,380
New +$36.8K 0.01% 1565
2025
Q3
Sell
-66,427
Closed -$146K 1890
2025
Q2
$146K Buy
66,427
+22,069
+50% +$36.1K 0.02% 1106
2025
Q1
$51.5K Buy
+44,358
New +$65.3K 0.01% 1448

Other funds holding EDIT

State of Wyoming's EDIT Position: Q2 2026 in Review

State of Wyoming increased its Editas Medicine (EDIT) stake by 24% in Q2 2026, buying an estimated $12.2K and bringing the position to 21,540 shares worth $69.8K. The position accounts for 0.01% of the portfolio, ranked #1583.

State of Wyoming first reported a position in EDIT in Q1 2025 and has held it in 4 quarters since. The position peaked at $146K in Q2 2025. 66 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • State of Wyoming held 21,540 shares of Editas Medicine worth $69.8K as of Q2 2026.
  • State of Wyoming bought 4,160 Editas Medicine shares in Q2 2026, an estimated $12.2K.
  • Editas Medicine made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1583 holding.
  • State of Wyoming first reported a position in Editas Medicine in Q1 2025 and has held it in 4 quarters since.
  • State of Wyoming's Editas Medicine position peaked at $146K in Q2 2025.
  • 66 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.